We demonstrated a predominant role for Ano1 in treatment resistance in Cyclin D1highAno1high HNSCC tumors and identified novel potential treatment combinations for this high-risk patient group. The gene discussed is ANO1; the disease is head and neck squamous cell carcinoma.